Guerrero J R, Martin S S
Med Res Rev. 1984 Jan-Mar;4(1):87-109. doi: 10.1002/med.2610040106.
Oral verapamil approved for use in all forms of angina, with its additional heart rate-controlling properties has undergone extensive clinical investigation and use since its initial development and has been demonstrated to be safe, well-tolerated and effective over a broad range of cardiovascular disorders. Further potential therapeutic indications for verapamil use remain to be assessed. Additional research with this exciting drug is ongoing.
口服维拉帕米被批准用于所有类型的心绞痛，因其具有额外控制心率的特性，自最初研发以来已进行了广泛的临床研究和应用，并已证明在广泛的心血管疾病中是安全、耐受性良好且有效的。维拉帕米使用的更多潜在治疗适应症仍有待评估。对这种令人兴奋的药物的进一步研究正在进行中。
